Endocrinology Flashcards
(168 cards)
What is the treatment of hypothyroidism?
Levothyroxine sodiu - drug of choice. Acts in the same way as endogenous thyroxine. It is converted to T3 in peripheral tissues, given orally usually once or twice daily. Start at maintenance dose but increase dose or frequency depending on clinical signs and TDM. Necessary to tailor to individual animal. Generally has good oral bioavailability in individuals may have reduced absorption. Half life of about 12-15 hours but individual animal variation. Thyrotoxicosis unusual.
What is hypothyroidism?
Primmarily a disease of dogs - lymphocytic thyroiditis, idiopathic atrophy. Diagnosis is based on clinical signs, serum haematology and biochemistry. measure bound and free T4 and also cTSH.
What is the difference between levothyroxine sodium tablets and levothyroxine sodium liquid?
Twice daily dosing often required for tablets. Therapeutic monitoring after 12 weeks, pre pill and 6 hours post pill (measure t3 and t4) required for Levothyroxine sodium. Liquid - once daily dosing, increased bioavailability vs tablets. Food decreases F value but can still give with food provided consistency. TDM 4-6 hours post treatment starting at 4 weeks.
What is liothyronine sodium?
Acts like endogenous T3 (triiodothyronine). It has a shorter duration of action and more rapidly metabolised. it is only used when there has been no or poor response to levothyroxine sodium. may be used to do a T3 suppression test in the diagnosis of equivocal hyperthyroidism in the cat.
What is hyperthyroidism?
Generally a condition of elderly cats. Usually associated with a benign adenoma of the thyroid gland leading to overproduction of thyroid hormones. Management/treatment - surgical removal of the thyroid, radioactive iodine treatment, drug therapy pre surgery or for long term management.
How do hyperthyroidism drugs work?
Prevent incorporation of thyroid peroxidase with thyroglovulin and therefore the production of T3 and T4. Most inhibit thyroid peroxidase - act as a preferential substrate, fail to get incorporation of iodide into the thyroglobulin molecule. Reduction in the production of T3 and T4. A number of drugs have been used - carbimazole, methimazole and proylthiouracil.
What is methimazole?
Licensed in the Uk for feline use. blocks thyroid peroxidase activity thus reducing levels of T3 and T4. The effects are reversible i.e control not cure. Can be used long term or prior to surgery (2-3 weeks). BID administration. Animals should be monitored every three weeks in terms of biochemistry, haematology and serum T4 levels for the first 4- months and thereafter every 3 months. Care especially in renal disease since GFR will b reduced. Especially at higher doses side effects not uncommon - but reversible. After oral absorption half life only 4-6 hours but may stay in the thyroid for about 20 hours. There is a great deal of variation in oral bioavailability and volume of distribution. It takes 1-3 weeks to see reduction in T4 levels. Preliminary work in transdermal administration, ease the problem of frequent oral dosing.
What is carbimazole?
Metabolised almost entirely to methimazole - appears to have fewer side effects than methimazole but not clear. Recently licensed for feline use in the UK - sustained release preparation for once daily dosing. half life 9 hours versus 5 hours for methimazole. Carbimazole less bitter. Do not crush or break tablets.
How is radioactive iodine used in hyperthyroidism?
131I is selectively taken up by the thyroid to be incorporated into thyroid hormone precursors. It emits beta and gamma radiation and so destroys the thyroid tissue. It is selective and not associated with damage to the surrounding tissue like the parathyroid. Special facilities and hospitalisation of the cat required post treatment as it is eliminated in faeces and urine.
What is hyperadrenocorticalism - cushings disease?
A relatively common endocrine abnormality in the dog. syndrome results from overproduction of cortisol and corticosterone from the adrenal gland. may be due to a pituitary adenoma or adrenal gland tumour. leeds to a large number of clinical signs and symptoms due to wide ranging effects of glucocorticoids.
How is trilostane used to treat hyperadrenocorticism?
UK licensed treatment for cushings disease - it Inhibits the enzyme 3- B hydroxysteroid dehydrogenase - inhibition is reversible. It reduces the production of cortisol and corticosterone. Does not consistently reduce aldosterone. Its oral bioavailability is improved with the presence of food. it has an active metabolite - ketotrilostane, elimination in the dog is not known. Close monitoring essential, given once daily, day 10 week 4 week 12 and every 3 months repeat ACTH stimulation test 4-6 hours post pill. Side effects - care with heart disease, vomiting, diarrhoea, pancreatitis, thromboembolism, adrenal necrosis, tablets should not be split.
What is mitotane?
Not available in the UK so imported on a special treatment certificate by applying to the VMD. Was the standard treatment prior to licensing of trilostane. If treatment with trilostane unsuccessful, mitotane may be used. related to DDT. Causes a selective destruction of the adrenal cortex zona fasciculata and zona reticularis. As it is a cytotoxic agent extreme care should be taken when handling and administering the drug. Induction phase and then maintenance phase. Daily treatment for about 7-14 days then once every 7-10 days. Generally mild side effects with lethargy vomiting diarrhoea. Occasionally get necrosis/destruction of the zona glomerulosa leading to addisonian crisis.
What is Addison’s disease?
Deficiency of mineralocorticoid and glucocorticoid production by the adrenal gland. Treatment involves mineralocorticoid and to a lesser extent glucocorticoid therapy. physiological replacement versus pharmacological effect. deficiency of adrenocortical steroid production. Mineralocorticoid and glucocorticoid deficiency. mostly in young female dogs. animals generally present collapsed, bradycardic, hyperkalaemic, hyponatraemic and dehydrated. Treated acutely with hydrocortisone, long term management with fludrocortisone.
What is DOCP?
Desoxycortisterone pivalate - available in US and canada - long acting analogue of DOCA. Given i/m approximately once every 25 days - tailor dose to individual animal.
Describe diabetes mellitus.
Insulin is produced by the B cells in the pancreas. there is extremely high interspecies sequence homology with porcine and canine insulin being identical. Type 1,2, and 3 diabetes mellitus all reflect an abnormality in glucose metabolism. type 1 is the most common in the dog. type 2 may be more important in the cat.
What are the functions of insulin?
Facilitates cellular uptake and metabolism of glucose, promotes synthesis of glycogen protein and fat, involved in the cellular uptake of ions such as K+.
What are the different types of insulin?
Short acting, intermediate, long acting. Insulin since it is a peptide hormone must be administered parenteraly. All preparations need to be stored between 2 to 8*. specialised syringed should be used. Insulin usually of bovine or porcine origin. Some of the human preparations are recombinant products.
Describe short acting insulin
Soluble insulin, neutral insulin
the only form of insulin that can be given Iv. may also be given im or sc. duration of activity when given i/v is about 2-4 hours. ideal for use in ketoacidotic emergencies- may b e administered as a constant rate infusion. can also be used in hyperkalaemia associated with UT obstruction.
Describe intermediate acting insulin
Onset of activity 1-2 hours; peak activity 6-12 hours, duration of effect 18-26 hours. often times are reduced in cats. Given s/c. Insulin Zinc suspension - mixture of 30% amorphous insulin zinc and 70% crystalline insulin zinc. Crystalline has a longer duration of action. Caninsulin is porcine origin (licensed).
Describe long acting insulin
onset of activity 4-6 hours, peak activity 14-24 hours, duration of effect 32-36 hours. Especally useful for cats where effect tends to be shortened vs the dog. Protamine zinc insulin - a bovine insulin administered s/c with slower release of insulin. Insulin glargine - new recombinant insulin, engineered to alter pharmacokinetic profile, acidic - ph4, don’t dilute or mix, injected s/c get micro precipitates to give relatively constant absorption profile. good results in cats where it is given twice daily in combination with a high protein low carb diet.
What are oral hypoglycaemic agents?
The sulphonylureas and the biguanides. Probably of limited use in veterinary species. may be tried in cats. No way of discerning type 1 or type 2. Sulphonylurea derivatives - stimulate the pancreas to release insulin, increase the peripheral utilisation of insulin, glipizide is main agent used - inhibits ATP dependent K+ channels causing depolarisation and release of insulin. Kinetics based on human studies show good oral bioavailability with hepatic metabolism and renal excretion.
Which drugs are used in diabetes insipidus?
D insipidus results either from a reduced release of vasopressin from the posterior pituitary or a reduce insensitivity to vasopressin in the collecting tubules. DDAVP - desmopressin is a vasopressin analogue - used in central diabetes insipidus. Does not possess the vasoconstrictor properties. DDAVP increases the retention of water in the collecting duct by the renal tubule by acting on V2 receptors, also increases the production of Von willebrands factor. It may be administered in the conjunctival sac lasting up to 8 hours. Chlorpropamide is an oral hypoglycaemic drug thought to increase NACL reabsorption in the ascending loop of henle - needs ADH to be present - nephrogenic DI.
What are the thiazide diuretics?
Used in D insipidus. Eg chlorthiazide - site of action D.C. T inhibit Na+ and Cl- reabsorption - so loss of sodium and water in the DCT leads to hypovolaemia. more sodium and water are reabsorbed in the PCT. less urine in the loop of henle - less urine presented to collecting tubule. May induce hypokalaemia.
What are microsomal triglyceride transport protein inhibitors?
MTP and apoliprotein B are key lipid transfer pproteins. MTP required for the formation of apoB containig lipoproteins. Chylomicron formation from GI tract and VLDL formation by the liver. This occurs within the enterocytes and the liver in the ER. Inhibiition of MTPS results in lowering of cholesterol and triglyceride levels. REduction in absorption of dietary fat and increased faecal excretion of fat. Eg Dirlotapide - an MTP inhibitor, selective inhibition of intestinal MTP - fatty acds, monoglycerides and cholesterol in the enterocyte do not get assembled into chylomicrons. Fat filled enterocytes triggers release of anorectic peptides- satiety centres to reduce food intake. oral administration required for effect to be seen.